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Abstract 
 
Cardiovascular Magnetic Resonance (CMR) perfusion imaging and Fractional Flow Reserve 
(FFR) assess myocardial ischemia. FFR measures the pressure loss across a stenosis 
determining hemodynamic significance but does not assess the area subtended by the 
stenotic vessel. CMR perfusion imaging measures the extent of myocardial blood flow 
reduction (= ischemic burden). Both techniques allow for continuous rather than categorical 
evaluation but their relationship is poorly understood. This study investigates the 
relationship between the FFR value and the extent of myocardial ischemia. 49 patients with 
angina underwent CMR perfusion imaging. FFR was measured in vessels with a visual 
diameter stenosis >40%. The extent of ischemia for each coronary artery was measured by 
delineating the perfusion defect on the CMR images and expressing as a percentage of the 
LV myocardium. The correlation between the extent of ischemia measured by CMR and FFR 
was good (r = -0.85, p<0.0005). The mean FFR value was 0.67 ± 0.17 and the mean perfusion 
defect was 8.9 ± 9.3%. An FFR value of ≥0.75 was not associated with ischemia on CMR. The 
maximum amount of ischemia (23.0±1.5%) was found at FFR values between 0.4 - 0.5. In 
patients with one vessel disease (49%) the mean ischemic burden was 15.3±8.3%. In 
patients with 2 vessel disease (18%) the mean ischemic burden was 26.0±12%.  
Reproducibility for measurement of ischemic burden was very good with a Kappa coefficient 
(k=0.826, p=0.048). In conclusion, there is good correlation between the FFR value and the 
amount of myocardial ischemia in the subtended myocardium.  
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Background 
 
In patients with stable coronary artery disease, international guidelines recommend 
proof of ischemia before revascularization1. This is based on an accumulating body of 
evidence showing improved outcome by guiding decisions on revascularization based on the 
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presence of ischemia2-5. This can be done non-invasively with myocardial perfusion imaging 
or invasively in the catheterization laboratory with the measurement of Fractional Flow 
Reserve (FFR). FFR is calculated as the ratio between aortic and distal coronary flow and 
allows differentiation between flow limiting and non-flow limiting lesions. FFR was initially 
validated against SPECT and DSE6-8  and later against outcome4,5. FFR does not, however, 
measure the amount of myocardium subtended by the stenotic vessel. CMR perfusion 
imaging allows non-invasive assessment of ischemia by visualizing the first pass of a contrast 
agent bolus through the myocardium. It enables direct visualization of a perfusion defect 
and therefore allows calculation of ischemic burden as a percentage of the myocardium. 
CMR first pass perfusion imaging is well validated against microspheres9,10  , outcome11  as 
well as in large prospective studies12,13 . In clinical practice a FFR cut-off value of 0.8 is used 
for guiding patient management. For perfusion studies, a cutoff value of 10-12.5% ischemic 
myocardium for SPECT and 2-3 (out of 32) myocardial segments for CMR has been 
recommended to define moderate to severe ischemia14. Several studies have compared the 
diagnostic accuracy of CMR perfusion imaging and FFR15-17 . However, a direct comparison 
between the FFR value and the ischemic burden measured by CMR has not previously been 
done. In this study, we sought to determine the relationship between FFR and ischemic 
burden measured by high resolution CMR imaging. 
 
Methods  
A total of 49 patients with typical symptoms (CCS class 1, 2 or 3) of angina were 
recruited into the study. They underwent CMR perfusion imaging and then angiography 
with FFR measurement within one month. The local research ethics committee approved 
the study and all patients gave written informed consent to participate. Exclusion criteria 
were any contra-indications to CMR scanning (i.e. claustrophobia, metallic implant, 
pacemaker insertion), contra-indications to adenosine therapy, previous coronary artery 
bypass grafts (CABG), recent myocardial infarction (MI) (within 6 months) and left 
ventricular (LV) ejection fraction <30%.  
Data were acquired with a 1.5T scanner (Achieva, Philips, Best, The Netherlands) 
using 32-channel coils. Examinations included high-resolution perfusion, cine and scar 
imaging. Perfusion imaging consisted of 3 short axis slices acquired every heartbeat covering 
16 of the standard myocardial segments (apex excluded)18 first during adenosine stress 
(140μg/kg/minute of adenosine administered intravenously for 4 minutes) followed by a 
short axis cine imaging stack and then rest imaging. Imaging parameters for perfusion 
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imaging: k-t blast acceleration factor 5, SSFP sequence, shortest TE (range 1.35-1.54ms), 
shortest TR (range 2.64-3.12ms), 50° flip angle; 90° prepulse, 100ms prepulse delay and 
typical acquired resolution 1.7 x 1.9 x 10mm. A dual bolus19 (equal volumes of 
0.0075mmol/kg followed by 0.075mmol/kg after a 20 second pause) of weight adjusted 
contrast agent (Gadobutrol/Gadovist, Bayer Healthcare, Germany) was injected at 4ml/s by 
a power injector for stress and rest imaging. The cine images were completed with a set of 
long axis views. Late gadolinium enhancement (LGE) images were acquired after 10 minutes 
(Gadovist 0.2mmol/kg cumulative dose) using an inversion recovery sequence. 
Two independent observers blinded to the angiographic data and clinical history 
analyzed the CMR perfusion images. A perfusion defect was defined as reduced contrast 
uptake at stress persisting for ≥4 consecutive dynamic time points but not present at rest. 
Each observer independently delineated LV endocardial and epicardial borders in all three 
slices to determine total myocardial area (Osirix software version 5.5.1. Pixeo, Switzerland). 
The ischemic area was delineated manually with the area of hypo-perfusion defined as the 
area with the least signal intensity (hypo-enhancement) in the stress perfusion dynamic 
with the clearest delineation of a perfusion defect. In patients with single vessel disease and 
one perfusion defect, the ischemic percentage was defined for that vessel as the area of 
hypo-enhancement normalized to ventricular area as calculated above. In multi-vessel 
disease, with two distinct perfusion defects it was possible to apply the same principle. In a 
confluent area, if it was difficult to distinguish two separate territories, then an arbitrary 
50% division was applied to each. Global ischemic burden was calculated by summing the 
individual perfusion defects. Designation of vascular territories was done according to 
American Heart Association (AHA) 16-segment classification20. In the presence of scar 
identified as areas of hyper-enhancement on late gadolinium imaging, the area of scar was 
quantified manually and subtracted from the area of hypo-enhancement. Inter- observer 
variability was determined by the comparison of the results from the two observers. 
Repeating the analysis of 10 cases after an interval of two weeks assessed intra-observer 
variability. 
Standard angiographic views using a Judkin’s technique were obtained. The 
procedure was covered with a weight-adjusted dose of unfractionated heparin. Pressure 
measurements were obtained in all coronary arteries with a diameter >2mm and >40% 
stenosis by visual assessment using a 0.014-inch intracoronary pressure wire (Volcano 
Therapeutics, San Diego, CA, USA, or Pressure-Wire Certus, St Jude Medical Systems AB, 
Uppsala, Sweden), during hyperemia (intravenous adenosine infused at 140μg kg/min for 
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three minutes). FFR was calculated as Pd/Pa, where Pd and Pa are distal coronary and aortic 
pressure respectively. A FFR of <0.75 was considered significant. Coronary occlusions or 
lesions of ≥99% were categorized as FFR-positive and a default FFR value of 0.5 was 
assigned. In cases of serial stenoses, the pressure sensor was positioned beyond the most 
distal lesion and if the FFR was positive, this was ascribed to the most proximal lesion 
Angiographic data was analyzed offline at the end of the study. Coronary 
dominance was designated on the basis of the origin of the posterior descending artery. 
Quantitative assessment of coronary artery percent narrowing was performed with MDQM-
QCA (Medcon Limited, Tel Aviv, Israel) software. Entirely smooth and occluded arteries were 
allocated 0% and 100% respectively. 
Data analysis was performed with SPSS version 20 (SPSS Inc., Chicago Illinois).  
Continuous variables were presented as mean ±SD. Correlations between normally and non-
normally distributed variables were tested by Pearson’s and Spearman’s methods 
respectively. Separate analyses were done, including and excluding the CTO data which had 
been assigned a default value of 0.5. Normality of distribution was tested by the Shapiro-
Wilk test. Differences in means between groups were compared using the ANOVA test for 
normally distributed populations and the Kruskal-Wallis test for non-normally distributed 
populations. Inter-observer variability of perfusion analysis was calculated using the kappa 
coefficient. Intra-observer variability was assessed by the use of the coefficient of variation 
from duplicate measurements. 
 
Results 
 The study protocol was successfully completed in all patients. Four scans had to be 
excluded from the CMR analysis due to uninterpretable CMR images, either due to the 
presence of artefact or the basal slice being too high to allow for accurate assessment of 
ischemic burden. The further analysis relates to the remaining patients. The demographic 
and clinical characteristics of these patients are listed in table 1.  
   Of all 147 arteries, 59 arteries had a stenosis >40% and were assessed with FFR. 8 
vessels were occluded. FFR done within the diagonal (n=4) and marginal branches (n=2) was 
included in the analysis of left anterior descending (LAD) artery and circumflex (CX) artery 
territories. No distal right coronary artery (RCA) branches were assessed. For angiographic 
details see table 2 and details of the CMR stress perfusion imaging hemodynamic response 
are given in table 3. 
There was very good correlation between the FFR values and the extent of ischemia 
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in all territories. Analysis 1 (including occluded vessels): the mean FFR value was 0.67 ± 0.17 
and the mean CMR perfusion defect size was 8.92 ± 9.3%. The correlation coefficient was r= 
-0.85, p<0.0005. See fig 1. Analysis 2 (excluding occluded vessels):  the mean value FFR value 
was 0.69 ± 0.17 and the mean CMR perfusion defect size was 8.39 ± 9.4%. The correlation 
coefficient was r= -0.85, p<0.005.  
When considering the different arterial territories individually, the correlation 
remained good within the LAD and RCA group: LAD r= -0.85 (p<0.005) RCA r= -0.81 
(p<0.005), the numbers were too small to calculate significance within the circumflex group. 
See Figure 3. There was no significant difference between the mean values of the three 
groups: LAD FFR 0.71 ± 0.15, CMR perfusion defect size 7.66 ± 9.0%; CX FFR 0.70 ± 0.21, 
CMR perfusion defect size 9.6 ± 10.7%; RCA FFR 0.61 ± 0.19, CMR perfusion defect size 12.2 
± 10.2%: H =2.178, p=0.336.  See table 4. 
When considering lesion location within the coronary arteries (analysis done for 
LAD only), mean values are as follows, Proximal LAD: FFR 0.65 ± 0.11, CMR perfusion defect 
10.3 ± 8.78%; Mid LAD FFR 0.68 ± 0.20, CMR perfusion defect 8.1 ± 10.4 %. 
At FFR values greater than 0.75, there was no myocardial perfusion defect in any 
patient. At values between 0.4–0.8 a linear relationship between FFR and CMR with very 
good correlation was found (r= -0.83, p<0.005) See Figure 3. The FFR values that correspond 
to an ischemic burden of between 10 – 12.5% are 0.64 and 0.67 respectively and are also 
demonstrated on figure 3. 
The amount of ischemia demonstrated by the extent of perfusion defect by CMR 
reached a peak between FFR values of 0.5- 0.4 (mean perfusion defect size: 23.0±1.5%). For 
FFR values <0.4 less ischemia was found by CMR (mean value 15.6 ±3.2%). There was a 
statistically significant difference between these three groups: H =35.141, p<0.005. See 
table 4. 
There was good correlation between the two observers in the measurement of CMR 
ischemia with a Kappa coefficient (k=0.826, p=0.048). Assessment of intra-observer 
variability demonstrated a co efficient of variation of 13% with a standard deviation of 
0.3319. 
 
 
 
Discussion  
This study demonstrates a number of findings: 
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1) FFR values between 0.75 and 0.4 correlate closely with the ischemic burden as 
determined by CMR perfusion imaging. 
2) An FFR value of greater than 0.75 is associated with no myocardial ischemia. 
3) The most extensive myocardial ischemia is demonstrated for FFR values between 
0.4 and 0.5. 
4) The maximum amount of ischemia caused by one artery is 25% of the myocardium. 
5) A 10-12.5% ischemic burden by CMR is found at FFR values of 0.64-0.67 
FFR is an index of the physiological importance of a particular stenosis and its effect on 
flow within the artery and therefore indicates the presence of a flow-limiting stenosis21. 
Currently, a significant FFR is used as a dichotomous variable signifying presence or absence 
of myocardial ischemia. However, the relationship between FFR value and extent of 
myocardial ischemia is poorly understood.  
We have shown that there is good correlation between the severity of a narrowing and 
the amount of ischemia present at a myocardial level. This is important for a number of 
reasons: firstly, it further validates the utility of FFR for the functional assessment of 
coronary lesions. Secondly, it demonstrates for the first time that the severity of FFR is 
related to the extent of myocardial ischemia. A larger pressure drop across a coronary 
stenosis is indicative of a greater flow limitation resulting in a lower FFR value. Our study 
confirms that this relationship also translates into a larger ischemic burden. Thirdly, it allows 
the development of FFR as a tool to assess ischemic burden. 
Our results demonstrate that the maximum amount of myocardium subtended by all 
three arteries is consistent (20 – 25%). While the study was not designed to subdivide FFR 
lesions to their exact anatomical location we found greater ischemia in proximal LAD lesions 
in comparison to mid LAD lesions despite similar FFR values. 
A study by Leone et al investigated the relationship between FFR and the amount of 
myocardium perfused further and demonstrated that an angiographically intermediate 
lesion is more likely to be functionally significant if there is a larger amount of perfused 
myocardium subtended by the stenosis22. They analyzed 213 intermediate stenoses (30- 
80% visual estimate) in 184 patients and found that lesions located in the proximal LAD 
were related to significantly lower FFR values and to a higher rate of positive FFR than those 
in the distal LAD, CX and RCA.  However, this study is limited by lack of direct visualization of 
the amount of ischemia caused which is calculated indirectly by myocardial jeopardy scores 
instead.  
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In addition to lesion location, the relationship between FFR, diameter stenosis and 
minimal lumen area has also been previously demonstrated23. However, it is noteworthy 
that in our study, even without controlling for similar lesion location and arterial diameter, 
we have demonstrated good correlation, suggesting that the actual FFR value may be one of 
the more important variables affecting extent of ischemia. 
This phenomenon has been investigated in a recently published meta-analysis, which 
also explores FFR as a continuous variable. Data from approximately 7000 patients was 
collated including the follow up for clinical events. The authors undertook a lesion level 
analysis which demonstrated that clinical events increased as FFR decreased, and 
revascularization showed larger net benefit for lower baseline FFR values24. 
Furthermore, data from the FAME 2 trial  also supports the notion that the benefit 
demonstrated in the percutaneous intervention (PCI) group may be related to the area of 
ischemia associated with the FFR value. The mean FFR value in both the medically treated 
and the PCI group was 0.68 in large epicardial arteries. The resultant large area of 
myocardium at risk may have contributed to the benefit demonstrated by treatment in the 
PCI group. This phenomenon is further highlighted when considering that the effects of PCI 
appeared to be more pronounced among patients who had lesions with an FFR of less than 
0.65 than among patients who had only lesions with larger FFR values (p<0.01).  These 
findings support our conclusion that a significant level of ischemia (10-12.5%)14 corresponds 
with an FFR value of 0.64-0.67. However,  just as in clinical practice an FFR of 0.80 is 
considered significant, so the extent of ischemia on CMR that is used to guide 
revascularization is often lower. A threshold of 5 % has been determined as significant in 
some trials2,25. Interestingly, we show that 5 % ischemia corresponds exactly with an FFR 
value of 0.75 (Fig 2), thus again supporting the notion that as the FFR value increases, the 
CMR perfusion defect decreases. The debate as to what level of FFR and CMR ischemia is 
deemed significant will no doubt continue. 
For FFR values less than 0.4, we observed a decrease in the extent of myocardial 
ischemia. This is unexpected and it is difficult to lay too much emphasis on this finding as 
the numbers are small.  While we are unable to provide a clear understanding of this 
phenomenon it is interesting to postulate on the role of collaterals and pre-conditioning etc. 
The presence of collaterals may reduce the extent of ischemia in the region supplied by the 
artery with the lowest FFR. It has previously been demonstrated that coronary artery 
disease progression, as measured by quantitative coronary analysis is associated with an 
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increase in collateral supply whereas regression in disease is associated with reduced 
collateral formation26. 
As mentioned earlier, for FFR values in the range of 0.4- 0.5, the extent of ischemia was 25% 
in patients. This observation was the same in all three arteries and is similar to a recent 3D 
CMR perfusion study by Manka et al27 .   
This study has a number of limitations. The sample size in this study is modest. 
However, this is the first study of this kind. Large sample sizes will be required to investigate 
how ischemic burden varies with lesion location and vessel size as alluded to earlier in the 
text. The matching of angiographic coronary arteries with territories on non-invasive 
imaging can never be exact. This could potentially lead to inaccuracies in assessment and 
allocation of ischemic burden. Additionally, assessing the relative contribution of two 
coronary arteries to one large area of perfusion defect involving adjacent territories is very 
subjective. For this study, qualitative visual assessment was used to reflect normal clinical 
practice. Fully quantitative perfusion analysis measuring absolute myocardial perfusion is 
slowly becoming available and may allow more accurate assessment of ischemic burden. 
However, since full quantification of perfusion by CMR is still a research tool within the 
validation stage we used a more established standard as the reference for this study. 3D 
perfusion may replace 2D perfusion as it allows for full coverage of the myocardium, which 
may further improve the quantification of ischemic burden28 . However, at this stage 3D 
imaging is not superior to 2D imaging  and has a lower in-plane spatial resolution.  
In conclusion, there is good correlation between FFR values and the extent of 
myocardial ischemia. FFR values above 0.75 are not associated with myocardial ischemia 
and ischemic burden increases linearly with smaller FFR values until a maximum ischemia of 
25% is found in myocardium subtended by arteries with FFR values between 0.4 and 0.5. 
This information could potentially be used to target revascularization to a subgroup of 
patients with a positive FFR and high ischemic burden. 
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Figure Title and Legend section:  
 
Figure 1: Scatter Plot of FFR values and % ischemia (All values) 
 
The FFR values of each vessel have been plotted against the amount of ischemic 
myocardium subtended by that vessel. The unfilled dots represent the chronically occluded 
arteries which have been assigned a default value of 0.5.  
 
 
 
 Figure 2: Scatter plot between FFR values 0.4-0.8   
 
 
Scatter plot of FFR values compared to ischemic burden of the corresponding vessel 
between the values of 0.4 and 0.8 demonstrating a linear relationship. The values for the 
occluded vessels have been removed and reference lines added to highlight the FFR values 
that correspond to the prognostically relevant ischemic burden threshold of 10 to 12.5%. 
 
Figure 3: Scatter plot demonstrating the relationship between FFR value and 
percentage ischemia for the different coronary territories (too few points in the 
circumflex territory to allow a regression analysis) 
 
 
Figure 4: Image of angiographic stenosis (a) and corresponding CMR images (b). 
 
CMR perfusion images (Fig 4a) showing the apical, mid and basal slices with a lateral 
perfusion defect. The endocardial and epicardial borders are delineated (green), the 
perfusion defect is segmented (red) and calculated as percentage of the total myocardial 
area.  In this case, the amount of ischemia measured is 21.5%. 
Figure 4b shows the angiographic images with a significant lesion in the circumflex artery 
The FFR value is 0.56. 
Abbreviations CMR: Cardiovascular Magnetic Resonance  
FFR: Fractional Flow Reserve 
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Table 1: Patient demographics and clinical characteristics (n=49) 
 
Parameter  Number or mean ± standard deviation 
Age (years) 61.9 ± 9.5 
Men 37 
Height (m) 1.71 ± 0.10 
Weight (kg) 80.9 ± 14.7 
Body Mass Index (kg/m2) 27.8 ± 3.8 
Diabetes Mellitus 15.7% 
Hypertension 58.8% 
Smoker 56.2% 
Hypercholesterolemia 91.3% 
Previous percutaneous intervention 12.0% 
Previous myocardial infarction 7.8% 
Canadian Class Symptoms  
1 5.9% 
2 85.3% 
3 8.8% 
4 0 
Drug therapy   
Aspirin 82.0% 
Statin 71.4% 
B blocker 60.0% 
ACE I 30.0% 
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Table 2: Angiographic Characteristics (n=49) 
 
 
Parameter Number or mean ± 
standard deviation 
No of FFR measurements (including occluded arteries) 59 
Number of occluded arteries 8 
Coronary artery with FFR >0.75 21 
Coronary artery with FFR <0.75 38 
Left anterior descending artery (including diagonal branch) 21 
Circumflex artery (including marginal branches) 4 
Right coronary artery 13 
Patients with FFR positive results  
        1- vessel disease 19 
        2- vessel disease 8 
        3-vessel disease 1 
QCA in vessels with FFR 0.75 (% diameter stenosis) 49.8 ± 33.1 
QCA in vessels with FFR >0.75 (% diameter stenosis) 85.0 ± 24.6 
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Table 3: Cardiovascular Magnetic Resonance perfusion imaging – Hemodynamic 
parameters (n=49) 
 
 
 
 
Variable  
Heart Rate (bpm) Rest  64 
Heart Rate (bpm) Stress 80 
Systolic Blood Pressure (mmHg) 
Rest 
 
136/77 
Systolic Blood Pressure 
(mmHg) Stress 
 
134/75 
Heart Rate Pressure Product 
(bpm x mmHg) Rest 
 
8704 
Heart Rate Pressure Product 
(bpm x mmHg) Stress 
 
10725 
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Table 4: Average ischemic area identified on Cardiovascular Magnetic Resonance 
perfusion imaging and Fractional Flow Reserve values per coronary territory and per 
Fractional Flow Reserve subgroup 
 
 
 
Territory/FFR subgroup Mean FFR value Mean CMR value (%) 
All arteries 0.67±0.17 8.92±9.35 
All arteries (-occluded arteries) 0.69±0.17 8.39±9.49 
Left anterior descending artery (All values) 0.71 ±0.15 8.01±9.3 
Proximal Left anterior descending artery 
(n=7) 
0.65± 0.11 10.3±8.77 
Mid Left anterior descending artery (n=10) 0.68±0.20 8.1±10.4 
Left anterior descending artery in 1 vessel 
disease (n=19) 
0.71± 0.13 6.5± 8.7 
Left anterior descending artery in 2-3 vessel 
disease (n=10) 
0.71± 0.13 9.71±10.5 
Right coronary artery 0.61 ±0.19 12.16±10.3 
Circumflex artery 0.70 ±0.21 9.63±10.8 
FFR value >0.75 0.81±0.07 0 
FFR value 0.51-0.75 0.65±0.06 12.7±8.1 
FFR value 0.4-0.5 0.46±0.02 23.02±1.53 
FFR value <0.4 0.27±0.05 15.63±3.2 
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